Evidence map›Paper›PMID 40165734›Full record

ArticleHaematologica2025

Emilio Iannitto, Simone Ferrero, Côme Bommier, Daniela Drandi, Martina Ferrante, Krimo Bouabdallah, Sylvain Carras, Guido Gini, Vincent Camus, Salvatrice Mancuso and 22 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors.

Emilio IannittoLa Maddalena Department of Oncology, Onco-Hematology and Bone Marrow Transplantation Unit, Palermo, Italy; Tumor Immunology Unit Department of Health Sciences, University of Palermo School of Medicine, Istituto di Patologia Generale, Palermo. emilio.iannitto@gmail.com.
Simone FerreroDivision of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino.
Côme BommierUniversitè Paris Citè, Paris, France; AP-HP, Hôpital Saint-Louis, Hemato-oncologie, Paris.
Daniela DrandiDivision of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino.
Martina FerranteDivision of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino.
Krimo BouabdallahCHU de Bordeaux - Hôpital Haut Lèvêque and Centre François Magendie, Service d'Hématologie Clinique et Thérapie Cellulaire, Pessac.
Sylvain CarrasUniversity Grenoble Alpes, Institute For Advanced Biosciences, INSERM U1209, CNRS UMR 5309, University Hospital, Molecular Biology and Hematology Departments, Grenoble.
Guido GiniEmatologia AOU delle Marche, Ancona.
Vincent CamusDepartment of Hematology, Centre Henri Becquerel, Rouen.
Salvatrice MancusoDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), Hematology Unit, University of Palermo.
Luigi MarcheselliFondazione Italiana Linfomi ETS, Modena.
Angela FerrariAzienda Unitá Sanitaria Locale-IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia.
Michele MerliHematology, Ospedale di Circolo e Fondazione Macchi - ASST Sette Laghi, Varese.
Benoit TessoulinNantes University Hospital and CRC2 NA, Nantes.
Caterina StelitanoUO Ematologia AO Bianchi-Melacrino-Morelli, Reggio Calabria.
Kheira BeldjordUniversitè Paris Citè, Paris.
Giovanni RotiDipartimento di Medicina e Chirurgia, Universitá di Parma, AOU di Parma, Parma.
Fabrice JardinEmatologia AOU delle Marche, Ancona.
Barbara CastagnariDepartment of Hematology, Ravenna Hospital, Ravenna.
Francesca PalombiHematology Unit, IRCCS Regina Elena National Cancer Institute, Roma.
Lucile BaseggioLaboratoire d'Hèmatologie Biologique, Groupement Hospitalier Lyon-Sud/Hospices Civils de Lyon, Lyon.
Alexandra Traverse-GlehenService d'Anatomie Pathologique, Groupement Hospitalier Lyon-Sud/Hospices Civils de Lyon, Lyon.
Claudio TripodoTumor Immunology Unit Department of Health Sciences, University of Palermo School of Medicine, Istituto di Patologia Generale, Palermo.
Anna Marina LiberatiOncohematology Unit, University of Perugia, Azienda Ospedaliera S. Maria, Terni.
Margherita ParoliniEmatologia, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"- IRST, Meldola.
Sara UsaiOspedale Oncologico A. Businco, Cagliari.
Caterina PattiU.O.C. di Oncoematologia Ospedali Riuniti Villa Sofia - Cervello, Palermo.
Massimo FedericoCHIMOMO Department, University of Modena and Reggio Emilia, Modena.
Maurizio MussoLa Maddalena Department of Oncology, Onco-Hematology and Bone Marrow Transplantation Unit, Palermo.
Marco LadettoUniversity of Eastern Piedmont, Amedeo Avogadro S.S. Antonio and Biagio and Cesaro Arrigo Hospital, Alessandria.
Emanuele ZuccaIOSI, Oncology Institute of Southern Switzerland and IOR, Institute of Oncology Research IELSG International Extranodal Lymphoma Study, Bellinzona.
Catherine ThieblemontUniversitè Paris Citè, Paris, France; AP-HP, Hôpital Saint-Louis, Hemato-oncologie, Paris.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40165734
PMCPMC11959258

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.